» Articles » PMID: 12707338

Influenza A Virus Infection Inhibits the Efficient Recruitment of Th2 Cells into the Airways and the Development of Airway Eosinophilia

Overview
Journal J Immunol
Date 2003 Apr 23
PMID 12707338
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Most infections with respiratory viruses induce Th1 responses characterized by the generation of Th1 and CD8(+) T cells secreting IFN-gamma, which in turn have been shown to inhibit the development of Th2 cells. Therefore, it could be expected that respiratory viral infections mediate protection against asthma. However, the opposite seems to be true, because viral infections are often associated with the exacerbation of asthma. For this reason, we investigated what effect an influenza A (flu) virus infection has on the development of asthma. We found that flu infection 1, 3, 6, or 9 wk before allergen airway challenge resulted in a strong suppression of allergen-induced airway eosinophilia. This effect was associated with strongly reduced numbers of Th2 cells in the airways and was not observed in IFN-gamma- or IL-12 p35-deficient mice. Mice infected with flu virus and immunized with OVA showed decreased IL-5 and increased IFN-gamma, eotaxin/CC chemokine ligand (CCL)11, RANTES/CCL5, and monocyte chemoattractant protein-1/CCL2 levels in the bronchoalveolar lavage fluid, and increased airway hyperreactivity compared with OVA-immunized mice. These results suggest that the flu virus infection reduced airway eosinophilia by inducing Th1 responses, which lead to the inefficient recruitment of Th2 cells into the airways. However, OVA-specific IgE and IgG1 serum levels, blood eosinophilia, and goblet cell metaplasia in the lung were not reduced by the flu infection. Flu virus infection also directly induced AHR and goblet cell metaplasia. Taken together, our results show that flu virus infections can induce, exacerbate, and suppress features of asthmatic disease in mice.

Citing Articles

Alloferon and Zanamivir Show Effective Antiviral Activity against Influenza A Virus (H1N1) Infection In Vitro and In Vivo.

Lee D, Jo H, Jang Y, Bae S, Agura T, Kang D Int J Mol Sci. 2023; 24(1).

PMID: 36614125 PMC: 9820929. DOI: 10.3390/ijms24010678.


Suppression of Allergic Asthma by Loss of Function of Miz1-mediated Th1 Skewing.

Do-Umehara H, Chen C, Zhang Q, Schleimer R, Budinger G, Liu J Am J Respir Cell Mol Biol. 2022; 67(3):346-359.

PMID: 35833903 PMC: 9447135. DOI: 10.1165/rcmb.2022-0135OC.


Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection.

Kang H, Chu K, Yoon K, Eom G, Mao J, Kim M Pathogens. 2021; 10(10).

PMID: 34684240 PMC: 8537550. DOI: 10.3390/pathogens10101291.


The interplay between airway epithelium and the immune system - A primer for the respiratory clinician.

Weinstock J, Chen X, Nino G, Koumbourlis A, Rastogi D Paediatr Respir Rev. 2021; 38:2-8.

PMID: 33812796 PMC: 8178232. DOI: 10.1016/j.prrv.2021.03.002.


Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19.

Kumar R, Lee M, Mickael C, Kassa B, Pasha Q, Tuder R ERJ Open Res. 2020; 6(4).

PMID: 33313306 PMC: 7720688. DOI: 10.1183/23120541.00405-2020.